Metrology

— Age-Related Outcomes A retrospective analysis involving Medicare patients suggested that hormone therapy in older women with breast cancer was linked to a lower risk of developing dementia. The study showed that breast cancer patients who underwent hormone-modulating therapy had a 7% reduced likelihood of dementia over an average follow-up of 12 years compared with those who didn’t receive the therapy (HR 0.93, 95% CI 0.88-0.98, P=0.005), according to research led by Chao Cai, PhD, from the